vs

Side-by-side financial comparison of 8X8 INC (EGHT) and NEOGENOMICS INC (NEO). Click either name above to swap in a different company.

NEOGENOMICS INC is the larger business by last-quarter revenue ($186.7M vs $185.1M, roughly 1.0× 8X8 INC). 8X8 INC runs the higher net margin — 2.8% vs -57.9%, a 60.6% gap on every dollar of revenue. On growth, NEOGENOMICS INC posted the faster year-over-year revenue change (11.1% vs 3.4%). Over the past eight quarters, NEOGENOMICS INC's revenue compounded faster (6.5% CAGR vs 1.6%).

8x8, Inc. is an American provider of cloud communications and customer experience software for businesses. The company offers unified communications, contact center, and communications platform as a service (CPaaS) delivered via a cloud-based architecture. 8x8 is headquartered in Campbell, California. Its common stock trades on the Nasdaq under the ticker symbol EGHT, and the company is led by Samuel Wilson.

NeoGenomics Laboratories, Inc., also known as NeoGenomics or Neo, is an American CLIA-certified clinical laboratory, pharma services and information services company that specializes in cancer genetics diagnostic testing. The company's testing services include cytogenetics, fluorescence in situ hybridization (FISH), flow cytometry, immunohistochemistry, anatomic pathology, and molecular genetics.

EGHT vs NEO — Head-to-Head

Bigger by revenue
NEO
NEO
1.0× larger
NEO
$186.7M
$185.1M
EGHT
Growing faster (revenue YoY)
NEO
NEO
+7.6% gap
NEO
11.1%
3.4%
EGHT
Higher net margin
EGHT
EGHT
60.6% more per $
EGHT
2.8%
-57.9%
NEO
Faster 2-yr revenue CAGR
NEO
NEO
Annualised
NEO
6.5%
1.6%
EGHT

Income Statement — Q3 FY2026 vs Q1 FY2026

Metric
EGHT
EGHT
NEO
NEO
Revenue
$185.1M
$186.7M
Net Profit
$5.1M
$-108.0M
Gross Margin
63.9%
43.3%
Operating Margin
5.2%
46.9%
Net Margin
2.8%
-57.9%
Revenue YoY
3.4%
11.1%
Net Profit YoY
68.4%
42.0%
EPS (diluted)
$0.04
$-0.13

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
EGHT
EGHT
NEO
NEO
Q1 26
$186.7M
Q4 25
$185.1M
$190.2M
Q3 25
$184.1M
$187.8M
Q2 25
$181.4M
$181.3M
Q1 25
$177.0M
$168.0M
Q4 24
$178.9M
$172.0M
Q3 24
$181.0M
$167.8M
Q2 24
$178.1M
$164.5M
Net Profit
EGHT
EGHT
NEO
NEO
Q1 26
$-108.0M
Q4 25
$5.1M
Q3 25
$767.0K
$-27.1M
Q2 25
$-4.3M
$-45.1M
Q1 25
$-5.4M
$-25.9M
Q4 24
$3.0M
Q3 24
$-14.5M
$-17.7M
Q2 24
$-10.3M
$-18.6M
Gross Margin
EGHT
EGHT
NEO
NEO
Q1 26
43.3%
Q4 25
63.9%
43.8%
Q3 25
64.8%
42.8%
Q2 25
66.4%
42.6%
Q1 25
67.8%
43.6%
Q4 24
67.7%
44.9%
Q3 24
68.1%
44.6%
Q2 24
67.9%
44.1%
Operating Margin
EGHT
EGHT
NEO
NEO
Q1 26
46.9%
Q4 25
5.2%
-7.1%
Q3 25
2.9%
-14.4%
Q2 25
0.3%
-26.3%
Q1 25
0.2%
-16.6%
Q4 24
5.0%
-10.7%
Q3 24
4.0%
-12.6%
Q2 24
-0.8%
-13.3%
Net Margin
EGHT
EGHT
NEO
NEO
Q1 26
-57.9%
Q4 25
2.8%
Q3 25
0.4%
-14.4%
Q2 25
-2.4%
-24.9%
Q1 25
-3.1%
-15.4%
Q4 24
1.7%
Q3 24
-8.0%
-10.5%
Q2 24
-5.8%
-11.3%
EPS (diluted)
EGHT
EGHT
NEO
NEO
Q1 26
$-0.13
Q4 25
$0.04
Q3 25
$0.01
Q2 25
$-0.03
Q1 25
$-0.04
Q4 24
$0.02
Q3 24
$-0.11
Q2 24
$-0.08

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
EGHT
EGHT
NEO
NEO
Cash + ST InvestmentsLiquidity on hand
$86.9M
$146.1M
Total DebtLower is stronger
$321.2M
Stockholders' EquityBook value
$142.9M
$828.8M
Total Assets
$661.5M
$1.3B
Debt / EquityLower = less leverage
2.25×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
EGHT
EGHT
NEO
NEO
Q1 26
$146.1M
Q4 25
$86.9M
$159.6M
Q3 25
$75.9M
$164.1M
Q2 25
$81.3M
$154.7M
Q1 25
$88.0M
$346.2M
Q4 24
$104.2M
$367.0M
Q3 24
$117.4M
$362.0M
Q2 24
$130.8M
$355.1M
Total Debt
EGHT
EGHT
NEO
NEO
Q1 26
Q4 25
$321.2M
$341.9M
Q3 25
$325.8M
Q2 25
$335.4M
Q1 25
$350.0M
Q4 24
$364.5M
$541.1M
Q3 24
$396.9M
Q2 24
Stockholders' Equity
EGHT
EGHT
NEO
NEO
Q1 26
$828.8M
Q4 25
$142.9M
$836.6M
Q3 25
$133.2M
$838.3M
Q2 25
$128.2M
$854.0M
Q1 25
$122.2M
$888.3M
Q4 24
$113.0M
$902.3M
Q3 24
$109.8M
$908.2M
Q2 24
$104.6M
$915.9M
Total Assets
EGHT
EGHT
NEO
NEO
Q1 26
$1.3B
Q4 25
$661.5M
$1.4B
Q3 25
$670.8M
$1.4B
Q2 25
$684.3M
$1.4B
Q1 25
$683.2M
$1.6B
Q4 24
$698.2M
$1.6B
Q3 24
$740.1M
$1.6B
Q2 24
$755.7M
$1.6B
Debt / Equity
EGHT
EGHT
NEO
NEO
Q1 26
Q4 25
2.25×
0.41×
Q3 25
2.45×
Q2 25
2.62×
Q1 25
2.86×
Q4 24
3.23×
0.60×
Q3 24
3.61×
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
EGHT
EGHT
NEO
NEO
Operating Cash FlowLast quarter
$20.7M
$-8.1M
Free Cash FlowOCF − Capex
$19.1M
FCF MarginFCF / Revenue
10.3%
Capex IntensityCapex / Revenue
0.9%
Cash ConversionOCF / Net Profit
4.07×
TTM Free Cash FlowTrailing 4 quarters
$43.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
EGHT
EGHT
NEO
NEO
Q1 26
$-8.1M
Q4 25
$20.7M
$1.3M
Q3 25
$8.8M
$8.9M
Q2 25
$11.9M
$20.3M
Q1 25
$5.9M
$-25.3M
Q4 24
$27.2M
$9.8M
Q3 24
$12.3M
$9.2M
Q2 24
$18.1M
$13.9M
Free Cash Flow
EGHT
EGHT
NEO
NEO
Q1 26
Q4 25
$19.1M
$-6.5M
Q3 25
$7.7M
$570.0K
Q2 25
$11.5M
$14.0M
Q1 25
$5.5M
$-29.8M
Q4 24
$26.8M
$-1.8M
Q3 24
$11.1M
$-1.6M
Q2 24
$17.8M
$814.0K
FCF Margin
EGHT
EGHT
NEO
NEO
Q1 26
Q4 25
10.3%
-3.4%
Q3 25
4.2%
0.3%
Q2 25
6.3%
7.7%
Q1 25
3.1%
-17.8%
Q4 24
15.0%
-1.0%
Q3 24
6.1%
-0.9%
Q2 24
10.0%
0.5%
Capex Intensity
EGHT
EGHT
NEO
NEO
Q1 26
Q4 25
0.9%
4.1%
Q3 25
0.6%
4.4%
Q2 25
0.2%
3.5%
Q1 25
0.2%
2.7%
Q4 24
0.3%
6.7%
Q3 24
0.7%
6.4%
Q2 24
0.2%
8.0%
Cash Conversion
EGHT
EGHT
NEO
NEO
Q1 26
Q4 25
4.07×
Q3 25
11.52×
Q2 25
Q1 25
Q4 24
9.01×
Q3 24
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

EGHT
EGHT

Services$179.7M97%
Other$5.4M3%

NEO
NEO

Segment breakdown not available.

Related Comparisons